Growth Hormone Deficiency Epidemiology Forecast and Market Analysis to 2024 - PowerPoint PPT Presentation

Loading...

PPT – Growth Hormone Deficiency Epidemiology Forecast and Market Analysis to 2024 PowerPoint presentation | free to download - id: 7b4cf5-OWY4Z



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Growth Hormone Deficiency Epidemiology Forecast and Market Analysis to 2024

Description:

RnRMarketResearch.com adds ‘EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2024 ’, to its store. – PowerPoint PPT presentation

Number of Views:13

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Growth Hormone Deficiency Epidemiology Forecast and Market Analysis to 2024


1
EpiCast Report Growth Hormone Deficiency -
Epidemiology Forecast to 2024 By
RnRMarketResearch
This is a premium report price at US3995 for a
single user PDF license
  • Browse more reports on Therapeutics at
  • http//www.rnrmarketresearch.com/reports/life-scie
    nces/pharmaceuticals/therapeutics .

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
2
EpiCast Report Growth Hormone Deficiency -
Epidemiology Forecast to 2024
  • Growth hormone deficiency (GHD) is an endocrine
    disorder characterized by low or deficient
    secretion of growth hormone (GH) secondary to
    malfunction of the pituitary gland, a pea-sized
    structure located at the base of the brain that
    is responsible for the production of GH. The
    International Classification of Diseases (ICD-10)
    ICD-10-CM code for GHD is E23.0.
  • GHD in children can be classified as idiopathic
    or organic, which is further divided into
    congenital and acquired. GH is necessary for
    normal growth, as it fuels childhood growth and
    development. In an adult's normal lifespan, GH is
    needed to maintain the amounts of body fat,
    muscle, and bone necessary for sustaining tissue
    and organ function.
  • Request a sample copy of this report at
    http//www.rnrmarketresearch.com/contacts/request-
    sample?rname413694 .

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
3
EpiCast Report Growth Hormone Deficiency
Epidemiology Forecast to 2024
In the 7MM, the diagnosed prevalent cases of GHD
for all ages and both sexes will increase from
97,985 cases in 2014 to 100,494 cases in 2024, at
an Annual Growth Rate (AGR) of 0.26. GlobalData
epidemiologists forecast a small increase in the
AGR of the diagnosed prevalent cases of GHD from
2014-2024 for all included markets except for
Germany and Japan. The majority of diagnosed
prevalent cases of GHD in children in the 7MM are
in boys. In the 7MM, 68.05 of the GHD cases in
children are in boys and the trend is consistent
in the individual markets. In adults, the
distribution is also skewed towards men in the US
and the 5EU.
http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
4
EpiCast Report Growth Hormone Deficiency
Epidemiology Forecast to 2024
  • Scope
  • The GHD epidemiology report is written and
    developed by Mastersand PhD-level
    epidemiologists.
  • The EpiCast Report is in-depth, high quality,
    transparent and market-driven, providing expert
    analysis of disease trends in the 7MM.
  • The Growth Hormone Deficiency (GHD) EpiCast
    Report provides an overview of the risk factors
    and global trends of GHD in the 7MM (US, France,
    Germany, Italy, Spain, UK, and Japan). It
    includes a 10-year epidemiological forecast for
    the GHD diagnosed in children (18 years) and in
    adults (gt18 years) segmented by sex from
    2014-2024.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
5
EpiCast Report Growth Hormone Deficiency
Epidemiology Forecast to 2024
  • Reasons to buy
  • Develop business strategies by understanding the
    trends shaping and driving the global GHD market.
  • Quantify patient populations in the global GHD
    market to improve product design, pricing, and
    launch plans.
  • Organize sales and marketing efforts by
    identifying the age groups and sex that present
    the best opportunities for GHD therapeutics in
    each of the markets covered.
  • Identify the percentage of GHD diagnosed
    prevalent cases by etiological classification.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
6
EpiCast Report Growth Hormone Deficiency
Epidemiology Forecast to 2024
  • For more details contact Mr. Ritesh Tiwari
    sales_at_rnrmarketresearch.com / 18883915441

RnRMarkertResearch RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR Market Research library has
syndicated reports by leading market research 
publishers across the globe.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
About PowerShow.com